While high levels of HER2 in cancer cells can give rise to homodimers that activate signaling, heterodimers between HER2 and EGFR (ErbB1/HER1) or HER2 and ErbB3/HER3 appear to be particularly important in breast cancer [1, 3, 6–9]. This evidence concerns the gene EGFR and breast carcinoma.